|
1
|
Wanebo HJ, Koness RJ, MacFarlane JK,
Eilber FR, Byers RM, Elias EG and Spiro RH: Head and neck sarcoma:
Report of the Head and Neck Sarcoma Registry. Society of Head and
Neck Surgeons Committee on Research. Head Neck. 14:1–7. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bernstein JM, Irish JC, Brown DH,
Goldstein D, Chung P, Razak A, Catton C, Gilbert RW, Gullane PJ and
O'Sullivan B: Survival outcomes for cutaneous angiosarcoma of the
scalp versus face. Head Neck. 39:1205–1211. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mendenhall WM, Mendenhall CM, Werning JW,
Reith JD and Mendenhall NP: Cutaneous angiosarcoma. Am J Clin
Oncol. 29:524–528. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pawlik TM, Paulino AF, McGinn CJ, Baker
LH, Cohen DS, Morris JS, Rees R and Sondak VK: Cutaneous
angiosarcoma of the scalp: A multidisciplinary approach. Cancer.
98:1716–1726. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ye J, Li XF, Wang YD and Yuan Y: Long-term
survival of a patient with scalp angiosarcoma and multiple
metastases treated using combination therapy: A case report. Oncol
Lett. 9:1725–1728. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin SC and Chang TS: Cutaneous
angiosarcoma of the scalp mimicking facial cellulitis. Ear Nose
Throat J. 95:438–440. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fury MG, Antonescu CR, Van Zee KJ, Brennan
MF and Maki RG: A 14-year retrospective review of angiosarcoma:
Clinical characteristics, prognostic factors, and treatment
outcomes with surgery and chemotherapy. Cancer J. 11:241–247. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Perez MC, Padhya TA, Messina JL, Jackson
RS, Gonzalez RJ, Bui MM, Letson GD, Cruse CW, Lavey RS, Cheong D,
et al: Cutaneous angiosarcoma: A Single-Institution experience. Ann
Surg Oncol. 20:3391–3397. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guadagnolo BA, Zagars GK, Araujo D, Ravi
V, Shellenberger TD and Sturgis EM: Outcomes after definitive
treatment for cutaneous angiosarcoma of the face and scalp. Head
Neck. 33:661–667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ogawa K, Takahashi K, Asato Y, Yamamoto Y,
Taira K, Matori S, Iraha S, Yagi N, Yogi A, Haranaga S, et al:
Treatment and prognosis of angiosarcoma of the scalp and face: A
retrospective analysis of 48 patients. Br J Radiol. 85:e1127–e1133.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Patel SH, Hayden RE, Hinni ML, Wong WW,
Foote RL, Milani S, Wu Q, Ko SJ and Halyard MY: Angiosarcoma of the
scalp and face: The Mayo clinic experience. JAMA Otolaryngol Head
Neck Surg. 141:335–340. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee BL, Chen CF, Chen PC, Lee HC, Liao WC,
Perng CK, Ma H and Lin CH: Investigation of prognostic features in
primary cutaneous and soft tissue angiosarcoma after surgical
resection: A retrospective study. Ann Plast Surg. 78 (Suppl
2):S41–S46. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Abraham JA, Hornicek FJ, Kaufman AM,
Harmon DC, Springfield DS, Raskin KA, Mankin HJ, Kirsch DG,
Rosenberg AE, Nielsen GP, et al: Treatment and outcome of 82
patients with angiosarcoma. Ann Surg Oncol. 14:1953–1967. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Young RJ, Brown NJ, Reed MW, Hughes D and
Woll PJ: Angiosarcoma. Lancet Oncol. 11:983–9891. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morgan MB, Swann M, Somach S, Eng W and
Smoller B: Cutaneous angiosarcoma: A case series with prognostic
correlation. J Am Acad Dermatol. 50:867–874. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oashi K, Namikawa K, Tsutsumida A,
Takahashi A, Itami J, Igaki H, Inaba K and Yamazaki N: Surgery with
curative intent is associated with prolonged survival in patients
with cutaneous angiosarcoma of the scalp and face - a retrospective
study of 38 untreated cases in the Japanese population. Eur J Surg
Oncol. 44:823–829. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chow W, Amaya CN, Rains S, Chow M,
Dickerson EB and Bryan BA: Growth attenuation of cutaneous
angiosarcoma with propranolol-mediated β-blockade. JAMA Dermatol.
151:1226–1229. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singla S, Papavasiliou P, Powers B,
Gaughan J, von Mehren M, Watson JC and Farma JM: Challenges in the
treatment of angiosarcoma: A single institution experience. Am J
Surg. 208:254–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schlemmer M, Reichardt P, Verweij J,
Hartmann JT, Judson I, Thyss A, Hogendoorn PC, Marreaud S, Van
Glabbeke M and Blay JY: Paclitaxel in patients with advanced
angiosarcomas of soft tissue: A retrospective study of the EORTC
soft tissue and bone sarcoma group. Eur J Cancer. 44:2433–2436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gebhardt C, Ziegler B, Stadler S, Goerdt S
and Utikal J: Complete remission of treatment-refractory advanced
angiosarcoma of the scalp by protracted intralesional interleukin-2
therapy. Br J Dermatol. 172:1156–1158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Young RJ, Woll PJ, Staton CA, Reed MW and
Brown NJ: Vascular-targeted agents for the treatment of
angiosarcoma. Cancer Chemother Pharmacol. 73:259–270. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Young RJ and Woll PJ: Anti-angiogenic
therapies for the treatment of angiosarcoma: A clinical update.
Memo. 10:190–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Donghi D, Kerl K, Dummer R, Schoenewolf N
and Cozzio A: Cutaneous angiosarcoma: Own experience over 13 years.
Clinical features, disease course and immunohistochemical profile.
J Eur Acad Dermatol. 24:1230–1234. 2010. View Article : Google Scholar
|
|
24
|
Wada M, Horinaka M, Yasuda S, Masuzawa M,
Sakai T and Katoh N: PDK1 is a potential therapeutic target against
angiosarcoma cells. J DermatoL Sci. 78:44–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsuneki M, Kinjo T, Mori T, Yoshida A,
Kuyama K, Ohira A, Miyagi T, Takahashi K, Kawai A, Chuman H, et al:
Survivin: A novel marker and potential therapeutic target for human
angiosarcoma. Cancer Sci. 108:2295–2305. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shustef E, Kazlouskaya V, Prieto VG, Ivan
D and Aung PP: Cutaneous angiosarcoma: A current update. J Clin
Pathol. 70:917–925. 2017. View Article : Google Scholar : PubMed/NCBI
|
